Literature DB >> 28338235

Overexpression of Hsa-miR-320 Is Associated With Invasion and Metastasis of Ovarian Cancer.

Wei Wang1, Juan Yang2, Yuan-Yuan Xiang3, Jie Pi1, Jiang Bian4.   

Abstract

Ovarian cancer is one of the most common malignant tumor of female genital organs which ranks the third morbidity. We aimed to provide a better understanding of the mechanism of invasion and metastasis of ovarian cancer. The ovarian cancer samples were downloaded from GEO. Then clustering was performed to classify the stage of miRNAs based on the difference of prognosis and metastasis. Furthermore, the miRNAs model was build and the survival analysis processes was performed to observe the influence on prognosis, invasion and metastasis. At last, miRNAs co-expression network was built to explore the core miRNAs and the risk classification model was built to perform the risk assessment based on these core miRNAs. A total of 17 significantly differential expressed miRNAs were obtained. Functional enrichment of 1,488 target genes, pathways like cell cycle, focal adhesion, and pathways in cancer, which are closely related to the proliferation and metastasis of cancer cells were highly enriched, this indicate that these miRNAs are related to the proliferation and metastasis of cancer cells. The co-expressed network shows that the high expression of hsa-miR-320 indicated negative prognosis and high risk of metastasis. In conclusion, the expression level of hsa-miR-320 is highly related to the migration and invasion of cancer. The high expression of hsa-miR-320 directly indicated negative prognosis and high risk of metastasis. These findings reveal that hsa-miR-320 may serve as an important therapeutic target in ovarian cancer therapy. J. Cell. Biochem. 118: 3654-3661, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CO-REGULATION NETWORK; Hsa-miR-320; KAPLAN-MEIER; OVARIAN CANCER; miRNAs

Mesh:

Substances:

Year:  2017        PMID: 28338235     DOI: 10.1002/jcb.26009

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.

Authors:  Jing Zhang; Dongdong Gao; Hui Zhang
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

2.  Long non‑coding RNA NEAT1 promotes ovarian cancer cell invasion and migration by interacting with miR‑1321 and regulating tight junction protein 3 expression.

Authors:  Min Luo; Lei Zhang; Hongying Yang; Kaili Luo; Chen Qing
Journal:  Mol Med Rep       Date:  2020-08-11       Impact factor: 2.952

3.  MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.

Authors:  Honghong Zhang; Sijuan Xu; Xiaoli Liu
Journal:  Oncol Lett       Date:  2019-04-05       Impact factor: 2.967

4.  Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.

Authors:  Youyong Tang; Yajing Zhao; Xingguo Song; Xianrang Song; Limin Niu; Li Xie
Journal:  J Clin Lab Anal       Date:  2019-08-16       Impact factor: 2.352

5.  Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.

Authors:  Gaia Palmini; Cecilia Romagnoli; Simone Donati; Roberto Zonefrati; Gianna Galli; Francesca Marini; Teresa Iantomasi; Alessandra Aldinucci; Gigliola Leoncini; Alessandro Franchi; Giovanni Beltrami; Domenico Andrea Campanacci; Rodolfo Capanna; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

6.  The involvement of small heat shock protein in chemoresistance in ovarian cancer - in vitro study.

Authors:  Aleksandra Wyciszkiewicz; Michal S Lach; Joanna P Wróblewska; Marcin Michalak; Wiktoria M Suchorska; Alicja Kalinowska; Slawomir Michalak
Journal:  EXCLI J       Date:  2021-05-25       Impact factor: 4.068

7.  miR‑320‑3p is involved in morphine pre‑conditioning to protect rat cardiomyocytes from ischemia/reperfusion injury through targeting Akt3.

Authors:  Lan Cao; Shijun Chai
Journal:  Mol Med Rep       Date:  2020-05-27       Impact factor: 2.952

8.  Exosomal microRNAs as tumor markers in epithelial ovarian cancer.

Authors:  Chi Pan; Ines Stevic; Volkmar Müller; Qingtao Ni; Leticia Oliveira-Ferrer; Klaus Pantel; Heidi Schwarzenbach
Journal:  Mol Oncol       Date:  2018-10-09       Impact factor: 6.603

9.  Diagnostic value of derived neutrophil-to-lymphocyte ratio in patients with ovarian cancer.

Authors:  Yang-Yang Wu; Yuan-Yuan Qin; Jin-Qiu Qin; Xuan Zhang; Fa-Quan Lin
Journal:  J Clin Lab Anal       Date:  2019-01-21       Impact factor: 2.352

10.  Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR / ALK wild-type advanced non-small cell lung cancer.

Authors:  Xiao-Xiao Peng; Ruoying Yu; Xue Wu; Shu-Yu Wu; Can Pi; Zhi-Hong Chen; Xu-Chao Zhang; Cun-Yi Gao; Yang W Shao; Li Liu; Yi-Long Wu; Qing Zhou
Journal:  J Immunother Cancer       Date:  2020-01       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.